By Professor Michael Leonard Friedlander

Journal articles

De Souza PL; Friedlander ML, 1995, 'Humoral hypercalcemia associated with adenocarcinoma of the rectum: A case report and review of the literature', American Journal of Clinical Oncology Cancer Clinical Trials, 18, pp. 126 - 129, http://dx.doi.org/10.1097/00000421-199504000-00006

Leary JA; Kerr J; Chenevix‐Trench G; Doris CP; Hurst T; Houghton CRS; Friedlanders ML, 1995, 'Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer', International Journal of Cancer, 64, pp. 189 - 195, http://dx.doi.org/10.1002/ijc.2910640308

Shannon JA; Donnellan MJ; Friedlander ML; Harnett PR, 1995, 'Persisting elevation of alphafetoprotein after chemotherapy for germ cell tumour-not always due to viable malignancy?', European Journal of Cancer, 31, pp. 1722, http://dx.doi.org/10.1016/0959-8049(95)00303-Z

Zalcberg JR; Bishop JF; Millward MJ; Zimet A; Laird J; Barter C; Seward D; McKeage MJ; Friedlander ML; Toner G; Berille J; Blanc C, 1995, '1084 Interim results of a phase II trial of docetaxel in combination with cisplatin in patients with metastatic or locally advanced non-small cell lung cancer (NSCLC)', European Journal of Cancer, 31, pp. S226 - S226, http://dx.doi.org/10.1016/0959-8049(95)96330-g

ISRAEL AA; FRIEDLANDER M; NEORI A, 1995, 'BIOMASS YIELD, PHOTOSYNTHESIS AND MORPHOLOGICAL EXPRESSION OF ULVA-LACTUCA', BOTANICA MARINA, 38, pp. 297 - 302, http://dx.doi.org/10.1515/botm.1995.38.1-6.297

GONEN Y; KIMMEL E; FRIEDLANDER M, 1995, 'DIFFUSION BOUNDARY-LAYER TRANSPORT IN GRACILARIA-CONFERTA (RHODOPHYTA)', JOURNAL OF PHYCOLOGY, 31, pp. 768 - 773, http://dx.doi.org/10.1111/j.0022-3646.1995.00768.x

Links M; Friedlander M, 1995, 'High-dose chemotherapy in gynaecological cancers', Current Opinion in Obstetrics and Gynecology, 7, pp. 49 - 52, http://dx.doi.org/10.1097/00001703-199502000-00010

Van Der Velden J; Gitch G; Wain GV; Friedlander ML; Hacker NF, 1995, 'Tamoxifen in patients with advanced epithelial ovarian cancer', International Journal of Gynecological Cancer, pp. 301 - 305

Gitch G; Friedlander ML; Wain GV; Hacker NF, 1995, 'Uterine papillary serous carcinaoma: a clinical study', Cancer, pp. 2239 - 2243

FRIEDLANDER M; LEWIS C; GOLDSTEIN D, 1994, 'UNTITLED', MEDICAL JOURNAL OF AUSTRALIA, 161, pp. 638 - 638, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PT68600027&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

SEGELOV E; FRIEDLANDER M, 1994, 'PROGNOSTIC FACTORS FOR WOMEN WITH OVARIAN GERM-CELL TUMORS - REPLY', JOURNAL OF CLINICAL ONCOLOGY, 12, pp. 1738 - 1738, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1994PA25700031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Chenevix-Trench G; Kerr J; Friedlander M; Hurst T; Sanderson B; Coglan M; Ward B; Leary J; Khoo SK, 1994, 'Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors', American Journal of Human Genetics, 55, pp. 143 - 149

Segelov E; Stuart-Harris R; Bell D; Tattersall M; Hutton-Potts J; Friedlander M, 1994, 'A phase II study of carboplatin and cisplatin in advanced ovarian cancer', European Journal of Gynaecological Oncology, 15, pp. 277 - 282

Segelov E; Campbell J; Ng M; Tattersall M; Rome R; Free K; Hacker N; Friedlander ML, 1994, 'Cisplatin-based chemotherapy for ovarian germ cell malignancies: The Australian experience', Journal of Clinical Oncology, 12, pp. 378 - 384, http://dx.doi.org/10.1200/JCO.1994.12.2.378

Quinn M; Murray J; Friedlander M; Steigrad S; Khoo S; Marsden D; Hammond I; Jobling T, 1994, 'EMACO in High Risk Gestational Trophoblast Disease ‐ The Australian Experience', Australian and New Zealand Journal of Obstetrics and Gynaecology, 34, pp. 90 - 92, http://dx.doi.org/10.1111/j.1479-828X.1994.tb01047.x

De Souza P; Friedlander M; Wilde C; Kirsten F; Ryan M, 1994, 'Hypersensitivity reactions to etoposide: A report of three cases and review of the literature', American Journal of Clinical Oncology Cancer Clinical Trials, 17, pp. 387 - 389, http://dx.doi.org/10.1097/00000421-199410000-00005

Mayordomo JI; Paz-Ares L; Diaz-Puente MT; Lianes P; Garcia-Prats MD; Cortes-Funes H; Segelov E; Friedlander M, 1994, 'Prognostic factors for women with ovarian germ cell tumors [2]', Journal of Clinical Oncology, 12, pp. 1737 - 1738, http://dx.doi.org/10.1200/JCO.1994.12.8.1737

Mackintosh JF; Friedlander M; Lewis C; Goldstein D; Herrmann RP; Kearsley JH, 1994, 'Wanted: Guidelines for 'palliative' anti-cancer drug use [3]', Medical Journal of Australia, 161, pp. 638 - 639, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127659.x

GONEN Y; KIMMEL E; FRIEDLANDER M, 1994, 'ATTENUATION OF WATER VELOCITY AND INCIDENT LIGHT AS A FUNCTION OF SHAPE-PARAMETERS IN GRACILARIA', JOURNAL OF APPLIED PHYCOLOGY, 6, pp. 381 - 390, http://dx.doi.org/10.1007/BF02182154

LEVY I; FRIEDLANDER M, 1994, 'SEASONAL GROWTH-ACTIVITY OF LOCAL AND FOREIGN GRACILARIOID STRAINS IN ISRAEL', JOURNAL OF APPLIED PHYCOLOGY, 6, pp. 447 - 454, http://dx.doi.org/10.1007/BF02182397

Lewis CR; Segelov E; Goldstein D; Friedlander ML, 1993, 'Chemotherapy made easier.', Australian and New Zealand Journal of Medicine, 23, pp. 387 - 392, http://dx.doi.org/10.1111/j.1445-5994.1993.tb01440.x

Leary JA; Doris CP; Boltz EM; Houghton CRS; Kefford RF; Friedlander ML, 1993, 'Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, 11p, 17p and 17q in ovarian cancer 11p, 17p and 17q in ovarian cancer', International Journal of Gynecological Cancer, 3, pp. 293 - 298, http://dx.doi.org/10.1046/j.1525-1438.1993.03050293.x

FRIEDLANDER M; DAWES C; LEVY I, 1993, 'EXPOSURE OF GRACILARIA TO VARIOUS ENVIRONMENTAL-CONDITIONS .1. THE EFFECT ON GROWTH', BOTANICA MARINA, 36, pp. 283 - 288, http://dx.doi.org/10.1515/botm.1993.36.4.283

Hornung H; Kress N; Friedlander M, 1992, 'TRACE ELEMENT CONCENTRATIONS IN INTERTIDAL ALGAE COLLECTED ALONG THE MEDITERRANEAN SHORE, ISRAEL', FRESENIUS ENVIRONMENTAL BULLETIN, 1, pp. 84 - 89

Leary JA; Edwards BG; Houghton CRS; Kefford RF; Friedlander ML, 1992, 'Amplification of HER-2/neu oncogene in human ovarian cancer', International Journal of Gynecological Cancer, 2, pp. 291 - 294, http://dx.doi.org/10.1046/j.1525-1438.1992.02060291.x

Levi JA; Wheeler HR; Friedlander M; Tattersall MHN; Kefford R; Dalley D, 1992, 'Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix', Gynecologic Oncology, 45, pp. 329 - 333, http://dx.doi.org/10.1016/0090-8258(92)90314-9

Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PO; Friedlander M; Khoo SK, 1992, 'Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus', Oncogene, 7, pp. 1059 - 1065

De Souza PL; Friedlander ML, 1992, 'Prognostic factors in ovarian cancer', Hematology Oncology Clinics of North America, 6, pp. 761 - 781, http://dx.doi.org/10.1016/s0889-8588(18)30309-5

Friedlander M; De Souza P; Segelov E, 1992, 'Risk factors, epidemiology, screening, and prognostic factors in female genital cancer', Current Opinion in Oncology, 4, pp. 913 - 922, http://dx.doi.org/10.1097/00001622-199210000-00016

FRIEDLANDER M, 1992, 'GRACILARIA-CONFERTA AND ITS EPIPHYTES - THE EFFECT OF CULTURE CONDITIONS ON GROWTH', BOTANICA MARINA, 35, pp. 423 - 428, http://dx.doi.org/10.1515/botm.1992.35.5.423

Cope C; Rowe D; Delbridge L; Philips J; Friedlander M, 1991, 'Comparison of image analysis and flow cytometric determination of cellular DNA content', Journal of Clinical Pathology, 44, pp. 147 - 151, http://dx.doi.org/10.1136/jcp.44.2.147

Friedlander ML; Dembo AJ, 1991, 'Prognostic factors in ovarian cancer', Seminars in Oncology, 18, pp. 205 - 212

Cope C; Delbridge L; Philips E; Friedlander M, 1991, 'PROGNOSTIC SIGNIFICANCE OF NUCLEAR DNA CONTENT IN PHAEOCHROMOCYTOMA', Australian and New Zealand Journal of Surgery, 61, pp. 695 - 698, http://dx.doi.org/10.1111/j.1445-2197.1991.tb00323.x

Friedlander M, 1991, 'CURRENT GENITOURINARY CANCER SURGERY', Australian and New Zealand Journal of Medicine, 21, pp. 492 - 492, http://dx.doi.org/10.1111/j.1445-5994.1991.tb01367.x

FRIEDLANDER M, 1991, 'GROWTH-RATE, EPIPHYTE BIOMASS AND AGAR YIELD OF GRACILARIA-CONFERTA IN AN ANNUAL OUTDOOR EXPERIMENT .1. IRRADIANCE AND NITROGEN', BIORESOURCE TECHNOLOGY, 38, pp. 203 - 208, http://dx.doi.org/10.1016/0960-8524(91)90155-D

FRIEDLANDER M; KROM MD; BENAMOTZ A, 1991, 'THE EFFECT OF LIGHT AND AMMONIUM ON GROWTH, EPIPHYTES AND CHEMICAL-CONSTITUENTS OF GRACILARIA-CONFERTA IN OUTDOOR CULTURES', BOTANICA MARINA, 34, pp. 161 - 166, http://dx.doi.org/10.1515/botm.1991.34.3.161

FRIEDLANDER M; BENAMOTZ A, 1991, 'THE EFFECT OF OUTDOOR CULTURE CONDITIONS ON GROWTH AND EPIPHYTES OF GRACILARIA-CONFERTA', AQUATIC BOTANY, 39, pp. 315 - 333, http://dx.doi.org/10.1016/0304-3770(91)90006-Q

FRIEDLANDER M; GALAI N; FARBSTEIN H, 1990, 'A MODEL OF SEAWEED GROWTH IN AN OUTDOOR CULTURE IN ISRAEL', HYDROBIOLOGIA, 204, pp. 367 - 373, http://dx.doi.org/10.1007/BF00040258

LEVY I; BEER S; FRIEDLANDER M, 1990, 'GROWTH, PHOTOSYNTHESIS AND AGAR IN WILD-TYPE STRAINS OF GRACILARIA-VERRUCOSA AND GRACILARIA-CONFERTA (GRACILARIALES, RHODOPHYTA), AS A STRAIN SELECTION EXPERIMENT', HYDROBIOLOGIA, 204, pp. 381 - 387, http://dx.doi.org/10.1007/BF00040260

Bishop JF; Kefford R; Raghavan D; Zalcberg J; Stuart-Harris R; Ball D; Olver IN; Friedlander M; Bull C; Yuen K; Matthews JP; Zimet A, 1990, 'Etoposide, carboplatin, cyclophosphamide and vincristine in previously untreated patients with small-cell lung cancer', Cancer Chemotherapy and Pharmacology, 25, pp. 367 - 370, http://dx.doi.org/10.1007/BF00686239

Boltz EM; Harnett P; Kefford RF; Leary J; Houghton R; Friedlander ML, 1990, 'Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting', British Journal of Cancer, 62, pp. 23 - 27, http://dx.doi.org/10.1038/bjc.1990.222

Bishop JF; Raghavan D; Olver IN; Reece P; Morris R; Friedlander ML, 1989, 'A phase I study of trimetrexate (NSC 352122) administered by 5-day continuous intravenous infusion', Cancer Chemotherapy and Pharmacology, 24, pp. 246 - 250, http://dx.doi.org/10.1007/BF00257627

Boltz EM; Kefford RF; Leary JA; Houghton CR; Friedlander ML, 1989, 'Amplification of c‐ras‐ki oncogene in human ovarian tumours', International Journal of Cancer, 43, pp. 428 - 430, http://dx.doi.org/10.1002/ijc.2910430314

Friedlander ML; Bell DR; Leary J; Davey RA, 1989, 'Comparison of Western blot analysis and immunocytochemical detection of P-glycoprotein in multidrug resistant cells', Journal of Clinical Pathology, 42, pp. 719 - 722, http://dx.doi.org/10.1136/jcp.42.7.719

Dalrymple JC; Bannatyne P; Russell P; Solomon HJ; Tattersall MHN; Atkinson K; Carter J; Duval P; Elliott P; Friedlander M; Murray J; Coppleson M, 1989, 'Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases', Cancer, 64, pp. 110 - 115, http://dx.doi.org/10.1002/1097-0142(19890701)64:1<110::AID-CNCR2820640120>3.0.CO;2-5

Boyer M; Friedlander M; Bannatyne P; Atkinson K, 1989, 'Hypercalcemia in association with mucinous adenocarcinoma of the ovary: A case report', Gynecologic Oncology, 35, pp. 387 - 390, http://dx.doi.org/10.1016/0090-8258(89)90085-1

Friedlander ML; Bell DR, 1989, 'Multidrug resistance: clinical findings and implications.', Cancer Treatment and Research, 42, pp. 63 - 77, http://dx.doi.org/10.1007/978-1-4613-1747-0_4

Friedlander ML; Quinn MA; Fortune D; Foo MS; Toppila M; Hudson CN; Russell P, 1989, 'The relationship of steroid receptor expression to nuclear DNA distribution and clinicopathological characteristics in epithelial ovarian tumors', Gynecologic Oncology, 32, pp. 184 - 190, http://dx.doi.org/10.1016/S0090-8258(89)80031-9

Antonjuk DJ; Boadle DK; Cheung HTA; Friedlander ML; Gregory PM; Tattersall MHN, 1989, 'α-Monoamides of methotrexate as potential prodrugs', Arzneimittel Forschung Drug Research, 39, pp. 12 - 15

Friedlander M; Leary J; Russelli P, 1988, 'An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: Correlation with histopathological features, prognostic variables and patient outcome', Pathology, 20, pp. 38 - 44, http://dx.doi.org/10.3109/00313028809085194

Back to profile page